Home/Filings/4/0001104659-21-114807
4//SEC Filing

Bertagnolli Monica 4

Accession 0001104659-21-114807

CIK 0001509745other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 9:01 PM ET

Size

8.0 KB

Accession

0001104659-21-114807

Insider Transaction Report

Form 4
Period: 2021-09-08
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-08+65,00065,000 total
    Exercise: $1.58Exp: 2031-09-07Common Stock (65,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-09-08+16,15016,150 total
    Exercise: $1.58Exp: 2031-09-07Common Stock (16,150 underlying)
Footnotes (2)
  • [F1]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 8, 2021, the Vesting Start Date.
  • [F2]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable with respect to 50% of the Option on September 30, 2021, and with respect to the remaining 50% of the Option on December 31, 2021.

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001761030

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 9:01 PM ET
Size
8.0 KB